Uncategorized
EyeTechCare raises €10 million to advance trial of ultrasound glaucoma device
EyeTechCare has completed a third round of funding, raising €10 million for an international clinical trial and the U.S. Food and Drug Administration registration process, according to a company news release.After the EyeMUST 1 trial on the EyeOP1 device, which involved about 60 glaucoma patients in France, EyeTechCare received a CE mark in May 2011 to begin marketing, sales and distribution activities for the noninvasive, ultrasound device, the release said.